Company
SIRPant
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
SIRPant generates a long-lived, multifaceted immune response against tumors, thereby acting as a cancer vaccine. This approach targets many cancer-associated antigens resulting in the production of
Loading relationship preview